dabigatran
Selected indexed studies
- Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism. (Paediatr Drugs, 2022) [PMID:35699915]
- Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions. (Curr Drug Metab, 2017) [PMID:28460624]
- [Dabigatran-induced oesophagitis]. (Ned Tijdschr Geneeskd, 2019) [PMID:31276328]
_Worker-drafted node — pending editorial review._
Connections
dabigatran is a side effect of
Sources
- Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism. (2022) pubmed
- Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions. (2017) pubmed
- [Dabigatran-induced oesophagitis]. (2019) pubmed
- Dabigatran-induced esophagitis. (2019) pubmed
- Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation. (2017) pubmed
- Dabigatran must be used carefully: literature review and recommendations for management of adverse events. (2019) pubmed
- Dabigatran: life-threatening bleeding. (2013) pubmed
- Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds. (2019) pubmed
- Drug interaction: dabigatran (Pradaxa) and statins. (2017) pubmed
- Dabigatran for the prevention and treatment of thromboembolic disorders. (2015) pubmed